Bernstein bevestiga qiimaynta dhexdhexaadka ah ee Fresenius Medical Care
Published
Bangiga maalgashiga Bernstein ayaa dib u xaqiijiyay qiimaynteeda dhexdhexaadka ah ee saamiga Fresenius Medical Care. Baadhitaanadooda gaarka ah ka dib, guriga falanqaynta ayaa ku sii waday talooyinkii hore. Taasi waxaa sheegay warbaahinta maaliyadda ee MarketScreener.
Fresenius Medical Care waa shirkad caafimaad oo Jarmalka ah oo xarunteeda ku taal Bad Homburg. Shirkadu waxay gaar ahaan ku takhasusaysay daaweynta cudurrada kelyaha, waxayna maamushaa xarumo dialysis-ka ah oo adduunka oo dhan ku yaal. Falanqeeyayaasha sida Bernstein ayaa shirkadaas si dhow u daba socda, sababtoo ah qiimayntooda waxay caawisaa maalgashadayaasha markay go'aan iibsashada ah qaadayaan.
Qiimayn dhexdhexaad ah waxay ka dhigan tahay in falanqeeyayaashu aanay saamiga si cad ugu talin iibsashada ama iibinta. Waxay malaynayaan in qiimaha saamigu wakhtiga soo socda uu u dhaqmi doono sida suuqa guud ahaan. Sidaas darteed, Bernstein hadda ma aragto sabab muhiim ah oo ay ugu baahan tahay inay qiimaynteeda beddesho.
Warbixintu ma bixinayso faahfaahin dheeraad ah oo ku saabsan baadhitaanadaas ama sababaha suurtagal ah ee go'aankaas. Sidaas darteed, maalgashadayaasha xiiseeya shirkadda waa inay sidoo kale akhriyaan warbixinnada rubuc-ahaan rasmiga ah iyo War-saxaafadeedka Fresenius Medical Care.
Sources: MarketScreener Deutschland
More Germany news
- Mercedes-Benz Halts Investment in German Plants and Weighs Closures
- Housing Benefit Cut Dropped: 1.3 Million Households Keep Wohngeld
- Align Technology unveils new innovations for Invisalign treatment
- Large Solar Park in Merbitz Feeds Electricity into the Grid
- Nvidia shares fall sharply: How safe is pension money?
- Telekom baut Rechenzentrum für Industrie und KI aus
- Autonomous Buses to Enter Everyday Life: TUM Leads New DZM Site
- Cigarettes from the EU Abroad: Duty-Free Allowance Not Dropping for Now